Bill Sponsor
Senate Bill 1971
117th Congress(2021-2022)
Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
Introduced
Introduced
Introduced in Senate on Jun 8, 2021
Overview
Text
Sponsor
Introduced
Jun 8, 2021
Latest Action
Jun 8, 2021
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1971
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Maryland
Republican
Missouri
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Chronic Kidney Disease Improvement in Research and Treatment Act of 2021

This bill modifies provisions relating to Medicare coverage of treatments for chronic kidney disease.

Specifically, the bill expands the Medicare annual wellness visit to include chronic kidney disease screening and allows certain Medicare beneficiaries who have End Stage Renal Disease to enroll in Medicare supplemental policies. It also (1) provides for alternative payment methodologies for certain new drugs, biologics, and devices that are renal dialysis services; (2) revises quality measures; (3) establishes an incentive payment methodology; and (4) increases access to kidney disease education services.

Text (1)
Actions (2)
06/08/2021
Read twice and referred to the Committee on Finance.
06/08/2021
Introduced in Senate
Public Record
Record Updated
Mar 8, 2023 8:12:35 PM